Form 4: Fractyl Health Director Samuel Conaway Acquires Shares in Open Market

Director Samuel Conaway of Fractyl Health, Inc. (GUTS) purchased 8,550 shares of common stock at a weighted average price of $1.1654 on March 13, 2025.

Summary

• On March 13, 2025, Samuel Conaway, a director of Fractyl Health, Inc. (GUTS), acquired 8,550 shares of common stock.
• The shares were purchased at a weighted average price of $1.1654, with individual prices ranging from $1.165 to $1.17.
• Following the transaction, Mr. Conaway directly owns 8,550 shares of Fractyl Health, Inc.

Sentiment

Score: 6

Explanation: Insider buying is generally viewed as a positive sign, suggesting confidence in the company's future. However, the size of the purchase is relatively small, so the impact is likely limited.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is required when a company insider (such as a director or officer) buys or sells shares of their company's stock. These filings are closely watched by investors as they can provide insights into management's view of the company's prospects.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates